Related Experiment Video
Updated: Jul 13, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Hepatitis B testing for liver cancer control among Korean Americans
Roshan Bastani1, Beth A Glenn, Annette E Maxwell
1Division of Cancer Prevention and Control Research, School of Public Health, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California 90095-6900, USA. bastani@ucla.edu
Introduction:
In Los Angeles County, Koreans surpass all other groups with respect to liver cancer incidence and mortality. An estimated 80%-85% of all liver cancer is etiologically related to chronic hepatitis B viral infection. Hepatitis B serologic testing of adult immigrants from highly endemic areas such as Asia is recommended as the first step in the control of hepatitis B infection and associated morbidities including liver cancer.
Objective:
To collect pilot data to obtain an initial understanding of hepatitis B serologic testing and vaccination rates and associated knowledge and beliefs in a community sample of Korean adults (N=141, 85% foreign born, mean age 45 years) in the greater Los Angeles area.
Design:
Cross-sectional survey.
Setting:
Five Korean Christian churches and one Korean-serving primary care clinic.
Results:
The hepatitis B serologic testing rate in our sample was 56%. Approximately one quarter of those tested reported that they were either chronic carriers or were immune as a result of a previous infection. Of those who remained susceptible to future infections, only 38% reported having been vaccinated. Constructs from our conceptual model, the Health Behavior Framework, were significant predictors of serologic testing, including hepatitis B knowledge, barriers to testing, and receipt of a physician's recommendation to get tested.
Conclusion:
Findings suggest that intervention research is urgently needed to increase hepatitis B awareness and testing among Korean American adults with subsequent vaccination and followup as indicated.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
